Compare
DaVita vs Labcorp (DVA vs LH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year DaVita (DVA) returned +57.9% and Labcorp (LH) +46.2%; so far this year the figures are +68.4% and +46.1%.
Labcorp is the larger company by market value, about 2.5 times the size of DaVita.
On trailing earnings, DVA trades at 14.2 times and LH at 30.1 times.
Revenue grew +6.4% at DVA and +6.0% at LH over the last year.
DVA pays no dividend. LH yields 0.79%.
Data as of the latest close. Not investment advice.
Relative performance
| DVA | LH | |
|---|---|---|
| Price | $191.35 | $366.57 |
| 1-day | -1.78% | +0.90% |
| YTD | +68.43% | +46.11% |
| 1 year | +57.93% | +46.22% |
| 3 years | +147.09% | +79.74% |
| Market cap | $12.0B | $29.8B |
| P/E | 14.2 | 30.1 |
| P/S | 0.85 | 2.04 |
| P/B | — | 3.36 |
| Revenue growth | +6.40% | +6.00% |
| EPS growth | +39.40% | +19.60% |
| Gross margin % | — | 29.0 |
| Net margin % | 6.5 | 6.9 |
| ROE % | — | 11.3 |
| Debt / equity | — | 0.66 |
| FCF yield % | 10.7 | 4.3 |
| Dividend yield % | — | 0.79 |
| Beta | -0.06 | 0.38 |
| RSI (14) | 56.0 | 69.9 |
| Technical rating |